Topical Voltaren in Otitis Externa

• Status: Terminated
• Trial end date: 2011-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Voltaren being a Non-steroidal anti-inflammatory drug (NSAID) drug may be used as a single drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption of oral analgesia.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Sieff Medical Center
• Treatments: Diclofenac

Criteria

Inclusion Criteria:

• Adults having otitis externa as single diagnosis mild to moderate

Exclusion Criteria:

• Diabetes

• Children

• Pregnant women

• Immune compromise

• Starting other treatment

• Moderate to severe otitis externa